| 1 |
35241487 | Experimental and Modeling Evidence Supporting the Trans-Inhibition Mechanism for Preincubation Time-Dependent, Long-Lasting Inhibition of Organic Anion Transporting Polypeptide 1B1 by Cyclosporine A. | 2022 May |
2 |
| 2 |
35292967 | Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions. | 2022 Jun |
1 |
| 3 |
35460165 | The pharmacokinetics of oral trazpiroben (TAK-906) after organic anion transporting polypeptide 1B1/1B3 inhibition: A phase I, randomized study. | 2022 Jun |
2 |
| 4 |
33538008 | Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis. | 2021 Sep |
1 |
| 5 |
31900032 | Plasma concentrations of pemafibrate with co-administered drugs predicted by physiologically based pharmacokinetic modeling in virtual populations with renal/hepatic impairment. | 2020 Sep |
1 |
| 6 |
32100958 | Genetic Diversity in Drug Transporters: Impact in African Populations. | 2020 Sep |
1 |
| 7 |
32166864 | Effect of Rifampin-Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel. | 2020 Sep |
2 |
| 8 |
32521634 | Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients. | 2020 Jun 8 |
1 |
| 9 |
32690641 | Rifampicin Transport by OATP1B1 Variants. | 2020 Sep 21 |
2 |
| 10 |
32719071 | Absence of OATP1B (Organic Anion-Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression. | 2020 Oct |
2 |
| 11 |
29405807 | Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3. | 2019 Feb |
1 |
| 12 |
30975793 | Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: "SLC-Phenotyping" Using Primary Human Hepatocytes. | 2019 Jul |
1 |
| 13 |
31129789 | Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug-Drug-Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole. | 2019 Dec |
2 |
| 14 |
31527775 | Imaging of hepatic drug transporters with [131I]6-β-iodomethyl-19-norcholesterol. | 2019 Sep 16 |
1 |
| 15 |
29226732 | Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization? | 2018 Jan |
1 |
| 16 |
27815731 | Hepatic Uptake Mechanism of Ophiopogonin D Mediated by Organic Anion Transporting Polypeptides. | 2017 Aug |
1 |
| 17 |
27858342 | Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs). | 2017 Aug |
3 |
| 18 |
28373111 | Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport. | 2017 Aug |
6 |
| 19 |
28535976 | Organic Anion-Transporting Polypeptide and Efflux Transporter-Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans. | 2017 Sep |
2 |
| 20 |
28594304 | Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. | 2017 Jun |
1 |
| 21 |
26482301 | Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. | 2016 Jan |
1 |
| 22 |
26684581 | Novel No-Wash Luminogenic Probes for the Detection of Transporter Uptake Activity. | 2016 Jan 20 |
1 |
| 23 |
27510251 | SLCO1B1 gene polymorphisms do not influence plasma rifampicin concentrations in a South Indian population. | 2016 Sep |
2 |
| 24 |
27631193 | SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine. | 2016 Sep |
1 |
| 25 |
27631194 | Mapping SLCO1B1 Genetic Variation for Global Precision Medicine in Understudied Regions in Africa: A Focus on Zulu and Cape Admixed Populations. | 2016 Sep |
1 |
| 26 |
25670521 | Organic anion transporting polypeptide-mediated transport of, and inhibition by, asunaprevir, an inhibitor of hepatitis C virus NS3 protease. | 2015 Feb |
1 |
| 27 |
26474710 | Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo. | 2015 Dec 7 |
3 |
| 28 |
24420746 | Factors associated with variability in rifampin plasma pharmacokinetics and the relationship between rifampin concentrations and induction of efavirenz clearance. | 2014 Mar |
2 |
| 29 |
24617605 | Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin. | 2014 Sep |
1 |
| 30 |
25116663 | Low rifampicin concentrations in tuberculosis patients with HIV infection. | 2014 Aug 13 |
2 |
| 31 |
23393219 | Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin. | 2013 May |
1 |
| 32 |
23400746 | Increased systemic exposure of fimasartan, an angiotensin II receptor antagonist, by ketoconazole and rifampicin. | 2013 Jan |
1 |
| 33 |
22499612 | PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me. | 2012 May |
1 |
| 34 |
22562052 | SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury. | 2012 Jul |
5 |
| 35 |
22638872 | Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions. | 2012 Oct |
1 |
| 36 |
21297316 | Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions. | 2011 Jun |
2 |
| 37 |
21372390 | Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes. | 2011 |
1 |
| 38 |
21430235 | Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. | 2011 Jun |
1 |
| 39 |
21456052 | Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions. | 2011 Apr |
3 |
| 40 |
21709081 | The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications. | 2011 Sep |
2 |
| 41 |
20406852 | Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. | 2010 Jul |
1 |
| 42 |
20540932 | Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3. | 2010 Oct 1 |
1 |
| 43 |
20660695 | Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations. | 2010 Oct |
3 |
| 44 |
19374892 | Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism. | 2009 Jul |
8 |
| 45 |
18413659 | Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin. | 2008 Aug |
1 |
| 46 |
18492796 | Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity. | 2008 Aug |
1 |
| 47 |
18509604 | Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies. | 2008 Aug |
1 |
| 48 |
17251982 | Inhibitory and inductive effects of rifampin on the pharmacokinetics of bosentan in healthy subjects. | 2007 Mar |
1 |
| 49 |
17496208 | Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. | 2007 Aug |
1 |
| 50 |
16479312 | Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells. | 2006 Jul |
2 |